for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Aramark

ARMK.N

Latest Trade

44.28USD

Change

0.04(+0.09%)

Volume

96,082

Today's Range

43.91

 - 

44.32

52 Week Range

25.50

 - 

44.79

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Aramark Names John Zillmer As CEO

Oct 7 (Reuters) - Aramark <ARMK.N>::ARAMARK NAMES INDUSTRY VETERAN JOHN ZILLMER AS CHIEF EXECUTIVE OFFICER.ARAMARK - STEVE SADOVE REMAINS CHAIRMAN, PAUL HILAL APPOINTED VICE CHAIRMAN.ARAMARK - ZILLMER, HILAL AND THREE NEW INDEPENDENT DIRECTORS APPOINTED TO BOARD, EFFECTIVE IMMEDIATELY.ARAMARK - ADDITIONAL NEW INDEPENDENT DIRECTOR TO JOIN BOARD AT 2020 ANNUAL MEETING.ARAMARK - ARAMARK'S BOARD WILL BE COMPRISED OF 11 DIRECTORS FOLLOWING ELECTION OF GREG CREED AT COMPANY'S 2020 ANNUAL MEETING.ARAMARK - OFFICE OF CHAIRMAN HAS BEEN DISSOLVED..

Aramark Issues Statement Regarding Mantle Ridge's Schedule 13-D Filing

Aug 16 (Reuters) - Aramark <ARMK.N>::STATEMENT REGARDING MANTLE RIDGE'S SCHEDULE 13-D FILING.FOCUSED ON MAXIMIZING LONG-TERM VALUE FOR ALL SHAREHOLDERS; WELCOMES OPEN COMMUNICATION & CONSTRUCTIVE DIALOGUE WITH SHAREHOLDERS.

Mantle Ridge Says Intends To Have Conversations, Meetings, Other Communications With Some Members Of Aramark's Board And Management

Aug 16 (Reuters) - Aramark <ARMK.N>::MANTLE RIDGE LP SAYS INTENDS TO HAVE CONVERSATIONS, MEETINGS & OTHER COMMUNICATIONS WITH SOME MEMBERS OF ARAMARK'S BOARD & MANAGEMENT.MANTLE RIDGE LP - MAY TAKE ACTIONS, INCLUDING SOLICITATION OF PROXIES, & MAY DISCUSS SUCH ACTIONS WITH ARAMARK'S BOARD, MANAGEMENT, STOCKHOLDERS.MANTLE RIDGE LP REPORTS 9.8% STAKE IN ARAMARK AS OF AUGUST 6, 2019 - SEC FILING.

Aramark Acquires On-Demand Food Delivery Service, Good Uncle

Aug 6 (Reuters) - Aramark <ARMK.N>::ARAMARK ACQUIRES ON-DEMAND FOOD DELIVERY SERVICE, GOOD UNCLE.ARAMARK - GOOD UNCLE WILL OPERATE INDEPENDENTLY.

Aramark Reports Q3 Adjusted Earnings Per Share $0.47

Aug 6 (Reuters) - Aramark <ARMK.N>::REPORTS THIRD QUARTER RESULTS.Q3 REVENUE $4.0 BILLION VERSUS REFINITIV IBES ESTIMATE OF $3.98 BILLION.Q3 EARNINGS PER SHARE $0.33.Q3 ADJUSTED EARNINGS PER SHARE $0.47.Q3 EARNINGS PER SHARE ESTIMATE $0.45 -- REFINITIV IBES DATA.BOARD AUTHORIZES SHARE REPURCHASE PROGRAM OF $200M THROUGH 2022.SEES 2019 ADJUSTED EPS OF $2.20 TO $2.30 PER SHARE.SEES FY 2019 FREE CASH FLOW OF $500 MILLION.SEES FY 2019 LEGACY BUSINESS REVENUE GROWTH EXPECTATIONS OF APPROXIMATELY 3%.

Aramark Reports Q2 Results

May 7 (Reuters) - Aramark <ARMK.N>::REPORTS SECOND QUARTER RESULTS.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $2.20 TO $2.30.Q2 EARNINGS PER SHARE $0.12.Q2 REVENUE $4.0 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.01 BILLION.Q2 ADJUSTED EARNINGS PER SHARE $0.45.Q2 EARNINGS PER SHARE ESTIMATE $0.49 -- REFINITIV IBES DATA.REAFFIRMING LEGACY BUSINESS REVENUE GROWTH EXPECTATIONS OF APPROXIMATELY 3% FOR 2019.REITERATING FULL-YEAR FREE CASH FLOW OUTLOOK OF $500 MILLION.FY2019 EARNINGS PER SHARE VIEW $2.35 -- REFINITIV IBES DATA.UPDATED 2019 ADJUSTED EPS OUTLOOK REFLECTS IMPACT OF STRATEGIC PORTFOLIO ACTIONS IN OUR INTERNATIONAL SEGMENT, AS WELL AS ADVERSE WEATHER.Q2 FSS US RESULTS IMPACTED BY WEATHER & CLIENT-RELATED REINVESTMENT COSTS.

Aramark Reports First Quarter Results

Feb 5 (Reuters) - Aramark <ARMK.N>::REPORTS FIRST QUARTER RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $0.63.Q1 REVENUE $4.3 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.19 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.61 -- REFINITIV IBES DATA.RAISES FY 2019 ADJUSTED EARNINGS PER SHARE VIEW TO $2.30 TO $2.40.Q1 EARNINGS PER SHARE $0.99.RAISING FULL-YEAR OUTLOOK.RAISING FULL-YEAR OUTLOOK.AFFIRMING ITS FULL-YEAR FREE CASH FLOW OUTLOOK OF $500 MILLION.QTRLY NET INCOME INCLUDES A NET GAIN ON SALE OF HEALTHCARE TECHNOLOGIES BUSINESS OF APPROXIMATELY $140 MILLION.STRONGER U.S. DOLLAR DECREASED REVENUE BY APPROXIMATELY $59 MILLION IN QUARTER.2019 ADJUSTED EPS OUTLOOK INCLUDES 4 CENTS OF CURRENCY HEADWINDS.

Aramark reports fourth quarter results

Nov 13 (Reuters) - Aramark <ARMK.N>::REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2018 EARNINGS.Q4 ADJUSTED EARNINGS PER SHARE $0.70.Q4 REVENUE $3.9 BILLION VERSUS I/B/E/S VIEW $3.95 BILLION.Q4 EARNINGS PER SHARE VIEW $0.71 -- THOMSON REUTERS I/B/E/S.BOARD INCREASES QUARTERLY DIVIDEND BY 5 PCT.BOARD OF DIRECTORS IS INCREASING REGULAR QUARTERLY DIVIDEND BY 5 PCT TO 11 CENTS PER SHARE OF COMMON STOCK.REVENUE GROWTH IN UNITED STATES SEGMENT WAS NEGATIVELY IMPACTED BY AN ESTIMATED $30 MILLION FROM NATURAL DISASTERS IN QUARTER.OPERATING INCOME NEGATIVELY IMPACTED BY ESTIMATED $11 MILLION FROM NATURAL DISASTERS IN QUARTER, PRIMARILY IN U.S. AND INTERNATIONAL SEGMENTS.

Cardinal Health Welcomes Victor Crawford As CEO Of Pharmaceutical Segment

Oct 15 (Reuters) - Cardinal Health Inc <CAH.N>::CARDINAL HEALTH WELCOMES VICTOR CRAWFORD AS CEO OF PHARMACEUTICAL SEGMENT.CARDINAL HEALTH - CRAWFORD'S MOST RECENT ROLE WAS CHIEF OPERATING OFFICER, HEALTHCARE, EDUCATION AND BUSINESS DINING FOR ARAMARK.

Aramark Announces Agreement For Sale Of Healthcare Technologies Business To Trimedx

Sept 17 (Reuters) - Aramark <ARMK.N>::ARAMARK ANNOUNCES AGREEMENT FOR SALE OF HEALTHCARE TECHNOLOGIES BUSINESS TO TRIMEDX.ARAMARK - DEAL FOR $300 MILLION TO TRIMEDX.ARAMARK - WILL USE MAJORITY OF PROCEEDS TO STRENGTHEN OUR BALANCE SHEET THROUGH DEBT REDUCTION.ARAMARK - WILL ALSO REPURCHASE $50 MILLION OF SHARES AFTER CLOSING OF SALE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up